Home > Financial Ratios > GLENMARK PHARMACEUTICALS

GLENMARK PHARMACEUTICALS
Working Capital/Sales

    Back to All Ratios
COMMUNITY POLL
for GLENMARK PHARMACEUTICALS
Please provide your vote to see the results

GLENMARK PHARMACEUTICALS Last 5 Year Working Capital/Sales History

[Consolidated]

Mar2025Mar2024Mar2023Mar2022Mar2021
   Working Capital/Sales(x) 8.8217.227.287.747.99

What is the latest Working Capital/Sales ratio of GLENMARK PHARMACEUTICALS ?

The latest Working Capital/Sales ratio of GLENMARK PHARMACEUTICALS is 8.82 based on Mar2025 Consolidated results.
Year Working Capital/Sales
Mar20258.82
Mar202417.22
Mar20237.28
Mar20227.74
Mar20217.99

How is Working Capital/Sales of GLENMARK PHARMACEUTICALS Trending?

Years Working Capital/Sales % Change
Mar2025 8.82
-48.78
Mar2024 17.22
136.54
Mar2023 7.28
-5.94
Mar2022 7.74
-3.13
Mar2021 7.99 -

Other Financial Ratios of GLENMARK PHARMACEUTICALS


Compare Working Capital/Sales ratio of peers of GLENMARK PHARMACEUTICALS

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
GLENMARK PHARMACEUTICALS ₹57,949.8 Cr 6.5% 0.1% 17.9% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹382,622.0 Cr 2% -2.3% -12.6% Stock Analytics
DIVIS LABORATORIES ₹159,536.0 Cr -1.3% -6.2% 21.2% Stock Analytics
CIPLA ₹125,468.0 Cr -2.2% 3.6% -4.5% Stock Analytics
TORRENT PHARMACEUTICALS ₹121,162.0 Cr -0% -0.3% 5% Stock Analytics
DR REDDYS LABORATORIES ₹105,874.0 Cr -0.9% 4.5% -8.6% Stock Analytics


GLENMARK PHARMACEUTICALS Share Price vs Sensex


Share Price Returns(%) 1 Week 1 Month 1 Year
GLENMARK PHARMACEUTICALS

6.5%

0.1%

17.9%

SENSEX

1.1%

-0.4%

-2.2%


You may also like the below Video Courses